Arguing against the proposed definition changes of PD

Movement Disorders

Volumn 31, Issue 11, 2016, Pages 1619-1622

  Boeve, Bradley F ^a   Dickson, Dennis W ^b   Duda, John E ^c   Ferman, Tanis J ^b   Galasko, Douglas R ^d   Galvin, James E ^e   Goldman, Jennifer G ^f   Growdon, John H ^g   Hurtig, Howard I ^c   Kaufer, Daniel I ^h   Kantarci, Kejal ^a   Leverenz, James B ⁱ   Lippa, Carol F ^j   Lopez, Oscar L ^k   McKeith, Ian G ^l   Singleton, Andrew B ^m   Taylor, Angela ⁿ   Tsuang, Debby ^o   Weintraub, Daniel ^p   Zabetian, Cyrus P ^o  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e FLORIDA ATLANTIC UNIVERSITY   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l NEWCASTLE UNIVERSITY   (United Kingdom)

^m NATIONAL INSTITUTE ON AGING   (United States)

ⁿ Lewy Body Dementia Association   (United States)

^o UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

dementia; Dementia with Lewy bodies; Parkinson's disease; parkinsonism

Indexed keywords

ALPHA SYNUCLEIN; ANTIPARKINSON AGENT; GLUCOSE; GLUCOSYLCERAMIDASE; NEUROTRANSMITTER;

ASSOCIATION; BEHAVIOR DISORDER; BRAIN ATROPHY; CLINICAL EVALUATION; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; DISEASE CLASSIFICATION; GENE DUPLICATION; GENE MUTATION; GLUCOSE UTILIZATION; HUMAN; MEMORY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; PARKINSON DISEASE; PATIENT CARE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; REM SLEEP; REVIEW; SLEEP DISORDER; SOCIAL SUPPORT; VISUAL PERCEPTION TEST; ADVISORY COMMITTEE; DEMENTIA; PHENOTYPE;

ADVISORY COMMITTEES; DEMENTIA; HUMANS; LEWY BODY DISEASE; PARKINSON DISEASE; PHENOTYPE;

EID: 84989323124     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26721     Document Type: Review

References (24)

1. Berg D, Postuma R, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord 2014;29:454–462.
2. Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004;63:2091–2096.
3. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002;59:1714–1720.
4. Johnson DK, Morris JC, Galvin JE. Verbal and visuospatial deficits in dementia with Lewy bodies. Neurology 2005;65:1232–1238.
5. Ferman T, Smith G, Kantarci K, et al. Non-amnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 2013;81:2032–2038.
6. Yoon J, Lee J, Yong S, Moon S, Lee P. The mild cognitive impairment stage of dementia with lewy bodies and Parkinson disease: a comparison of cognitive profiles. Alzheimer Dis Assoc Disord 2014;28:151–155.
7. Edison P, Rowe CC, Rinne JO, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psych 2008;79:1331–1338.
8. Gomperts SN. Imaging the role of amyloid in PD dementia and dementia with Lewy bodies. Cur Neurol Neurosci Rep 2014;14:472.
9. Boeve B, Silber M, Ferman T, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 2013;14:754–762.
10. Ferman T, Boeve B, Smith G, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 2011;77:875–882.
11. Gatt A, Jones E, Francis P, Ballard C, Bateman J. Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies. Neurosci Let 2013;557(Pt B):177–180.
12. Tsuang D, Leverenz J, Lopez O, et al. APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 2013;70:223–228.
13. Tsuang D, Leverenz JB, Lopez OL, et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 2012;79:1944–1950.
14. Bras J, Guerreiro R, Darwent L, et al. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Molec Gen 2014;23:6139–6146.
15. Evans JR, Mason SL, Williams-Gray CH, et al. The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 2011;82:1112–1118.
16. Aarsland D, Kvaloy JT, Andersen K, et al. The effect of age of onset of PD on risk of dementia. J Neurol 2007;254:38–45.
17. Savica R, Grossardt B, Bower J, Boeve B, Ahlskog J, Rocca W. Incidence of dementia with Lewy bodies and parkinsonism with dementia (P03.097). JAMA Neurol 2013;70:1396–1402.
18. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005;4:605–610.
19. Ballard C, Ziabreva I, Perry R, et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006;67:1931–1934.
20. Nelson P, Jicha G, Kryscio R, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol 2010;257:359–366.
21. McKeith I, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113–1124.
22. McKeith I, Dickson D, Lowe J, et al. Dementia with Lewy bodies: diagnosis and management: third report of the DLB Consortium. Neurology 2005;65:1863–1872.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.
24. Montine T, Koroshetz W, Babcock D, et al. Recommendations of the Alzheimer's disease-related dementias conference. Neurology 2014;83:851–860.